The aim of the study is to assess visual function from neonatal age to 36 months of age in infants at risk of visual impairment due to brain lesion or ocular pathology
Age between 34 weeks of post-menstrual age and 36 months of life in children born before 37 weeks gestational age
Genetic syndroms
Hypoxic Hischemic Encephalopathy
Brain malformation
Patients at low risk of developing neurological outcomes
Refusal of informed consent
Children at risk for visual impairment due to brain lesion, brain malformation, genetic syndroms, Hypoxic Hischemic Encephalopathy, metabolic diseases or ocular pathologies, assessed at neonatal age and followed up to 36 months of age
Cohort
Other
Not listed
Early Visual Functions in Patients at Risk of Developing Cerebral Visual Impairment. A Pilot Study
The score of the functional visual assessment will be obtained at neonatal age and at 1-3-6-9-12-18-24-36 months of life will be analysed at each age and compared to neurodevelopment findings using different scales according to age. These results will be related to the MRI total score (obtained by the sum of scores by site: cortex, basal ganglia, white matter and cerebellum, normal (0), mild abnormal (1), severely abnormal (2)).
Correlation betwwen functional visual assessment score to MRI score
Results of functional visual assessment will be related to the MRI total score (obtained by the sum of scores by site: cortex, basal ganglia, white matter and cerebellum, normal (0), mild abnormal (1), severely abnormal (2)).
Click on the lead sponsor to view all of their trials.
